methylphenidate and Affective Disorders
methylphenidate has been researched along with Affective Disorders in 14 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"Methylphenidate hydrochloride (Ritalin) has been used to treat both depression and apathy." | 9.05 | Methylphenidate in depression and states of apathy. ( Moore, DP, 1981) |
" We sought to prospectively study the effects of levodopa (LD) and/or methylphenidate (MPH) in combination with physiotherapy on mood and cognition following stroke in human subjects." | 6.76 | Effect of methylphenidate and/or levodopa combined with physiotherapy on mood and cognition after stroke: a randomized, double-blind, placebo-controlled trial. ( Delbari, A; Lokk, J; Salman-Roghani, R, 2011) |
"Methylphenidate hydrochloride (Ritalin) has been used to treat both depression and apathy." | 5.05 | Methylphenidate in depression and states of apathy. ( Moore, DP, 1981) |
" We sought to prospectively study the effects of levodopa (LD) and/or methylphenidate (MPH) in combination with physiotherapy on mood and cognition following stroke in human subjects." | 2.76 | Effect of methylphenidate and/or levodopa combined with physiotherapy on mood and cognition after stroke: a randomized, double-blind, placebo-controlled trial. ( Delbari, A; Lokk, J; Salman-Roghani, R, 2011) |
"The diagnosis of attention deficit disorder, residual type, should be considered in patients with prominent complaints of impulsivity, restlessness, emotional lability, and hot temper who do not suffer from schizophrenia or major mood disorder and do not have symptoms of schizotypal or borderline personality disorders." | 2.66 | A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. ( Reimherr, FW; Ward, M; Wender, PH; Wood, D, 1985) |
"Increased research focusing on the eating disorders has put the clinician on firmer ground when choosing appropriate psychopharmacologic treatments." | 2.37 | Pharmacologic treatment of eating disorders. ( Gwirtsman, H; Jimerson, DC; Kaye, W; Weintraub, M, 1984) |
"The most common comorbidities were substance use disorders (39." | 1.43 | Psychiatric Comorbidity at the Time of Diagnosis in Adults With ADHD: The CAT Study. ( Balanzá-Martínez, V; García-García, P; Piñeiro-Dieguez, B; Soler-López, B, 2016) |
"Methylphenidate (MPH) is a neural stimulant with unclear neurochemical and behavioral effects." | 1.43 | The neuroprotective effect of lithium against high dose methylphenidate: Possible role of BDNF. ( Asadi, M; Motaghinejad, M; Motevalian, M; Seyedjavadein, Z, 2016) |
"Patients with unipolar depression were studied in a drug-free baseline state following short-term administration of methylphenidate and in a euthymic state in long-term follow-up." | 1.27 | Positron emission tomographic study of affective disorders: problems and strategies. ( Baxter, L; Gerner, R; Mazziotta, JC; Phelps, ME, 1984) |
Research
Studies (14)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (28.57) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 2 (14.29) | 29.6817 |
2010's | 6 (42.86) | 24.3611 |
2020's | 1 (7.14) | 2.80 |
Authors
Authors | Studies |
---|---|
Friedrich, B | 1 |
Bridler, R | 1 |
Moukhtarian, TR | 1 |
Cooper, RE | 1 |
Vassos, E | 1 |
Moran, P | 1 |
Asherson, P | 1 |
Spada, MM | 1 |
Piñeiro-Dieguez, B | 1 |
Balanzá-Martínez, V | 1 |
García-García, P | 1 |
Soler-López, B | 1 |
Motaghinejad, M | 1 |
Seyedjavadein, Z | 1 |
Motevalian, M | 1 |
Asadi, M | 1 |
Spiegel, DR | 1 |
Kim, J | 1 |
Greene, K | 1 |
Conner, C | 1 |
Zamfir, D | 1 |
Auyeung, SF | 1 |
Long, Q | 1 |
Royster, EB | 1 |
Murthy, S | 1 |
McNutt, MD | 1 |
Lawson, D | 1 |
Miller, A | 1 |
Manatunga, A | 1 |
Musselman, DL | 1 |
Marcus, SC | 1 |
Durkin, M | 1 |
Delbari, A | 1 |
Salman-Roghani, R | 1 |
Lokk, J | 1 |
Gwirtsman, H | 1 |
Kaye, W | 1 |
Weintraub, M | 1 |
Jimerson, DC | 1 |
Phelps, ME | 1 |
Mazziotta, JC | 1 |
Baxter, L | 1 |
Gerner, R | 1 |
Moore, DP | 1 |
Suffin, SC | 1 |
Emory, WH | 1 |
Wender, PH | 1 |
Reimherr, FW | 1 |
Wood, D | 1 |
Ward, M | 1 |
Reviews
3 reviews available for methylphenidate and Affective Disorders
Article | Year |
---|---|
Effects of stimulants and atomoxetine on emotional lability in adults: A systematic review and meta-analysis.
Topics: Adult; Affective Symptoms; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; | 2017 |
An overview of problematic internet use.
Topics: Antidepressive Agents, Second-Generation; Behavior, Addictive; Central Nervous System Stimulants; Ci | 2014 |
Pharmacologic treatment of eating disorders.
Topics: Anorexia Nervosa; Anticonvulsants; Antidepressive Agents; Antidepressive Agents, Tricyclic; Central | 1984 |
Trials
3 trials available for methylphenidate and Affective Disorders
Article | Year |
---|---|
Effect of methylphenidate and/or levodopa combined with physiotherapy on mood and cognition after stroke: a randomized, double-blind, placebo-controlled trial.
Topics: Aged; Analysis of Variance; Antiparkinson Agents; Central Nervous System Stimulants; Cognition Disor | 2011 |
Methylphenidate in depression and states of apathy.
Topics: Clinical Trials as Topic; Depression; Double-Blind Method; Humans; Methylphenidate; Mood Disorders | 1981 |
A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Borderline Personality Disorder; Clinical Tria | 1985 |
Other Studies
8 other studies available for methylphenidate and Affective Disorders
Article | Year |
---|---|
Topics: Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Humans; Mania; Methylphenidate; Moo | 2020 |
Psychiatric Comorbidity at the Time of Diagnosis in Adults With ADHD: The CAT Study.
Topics: Adult; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Comorbidity; Cross-Sectiona | 2016 |
The neuroprotective effect of lithium against high dose methylphenidate: Possible role of BDNF.
Topics: Animals; Brain-Derived Neurotrophic Factor; Central Nervous System Stimulants; Cytokines; Disease Mo | 2016 |
Apathy due to cerebrovascular accidents successfully treated with methylphenidate: a case series.
Topics: Aged; Depression; Humans; Male; Methylphenidate; Middle Aged; Mood Disorders; Motivation; Stroke; Tr | 2009 |
Sequential multiple-assignment randomized trial design of neurobehavioral treatment for patients with metastatic malignant melanoma undergoing high-dose interferon-alpha therapy.
Topics: Behavioral Symptoms; Citalopram; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Doubl | 2009 |
Stimulant adherence and academic performance in urban youth with attention-deficit/hyperactivity disorder.
Topics: Achievement; Adolescent; Amphetamine; Anxiety Disorders; Attention Deficit and Disruptive Behavior D | 2011 |
Positron emission tomographic study of affective disorders: problems and strategies.
Topics: Bipolar Disorder; Depressive Disorder; Female; Glucose; Humans; Lithium; Male; Methylphenidate; Mood | 1984 |
Neurometric subgroups in attentional and affective disorders and their association with pharmacotherapeutic outcome.
Topics: Adolescent; Adult; Anticonvulsants; Antidepressive Agents; Attention Deficit Disorder with Hyperacti | 1995 |